Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5151439A · kind A · utility
3Cited by
21References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 1991 |
| Grant date | Sep 29, 1992 |
| Priority date | — |
| Expiry date | Aug 1, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D317/46
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention discloses substituted 1,3-benzodioxoles which possess anti-diabetic and/or anti-hyperglycemic and/or anti-obesity properties in humans and other animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.